Vaccines are a key tool for addressing antimicrobial resistance (AMR), both by preventing bacterial infections and reducing the use of antimicrobials. The full value of vaccines has not been realized due to regulatory, behavioral, and economic challenges.
This session will discuss the role vaccines play in addressing AMR. Specifically the session will consider how vaccine regulatory and access policies can be used to strengthen utilization of vaccines as a component of multi-pronged strategies that governments should take in their national action plans to address AMR. Existing data will be presented that demonstrates the value vaccines play, and the discussion will focus on additional data needed to strengthen the use of existing vaccines and vaccines currently in development.
Session ID: 36185